Candida auris -associated hospitalizations and outbreaks, China, 2018-2023

The emerging human fungal pathogen has become a serious threat to public health. This pathogen has spread to 10 provinces in China as of December 2023. Here we describe 312 -associated hospitalizations and 4 outbreaks in healthcare settings in China from 2018 to 2023. Three genetic clades of have been identified during this period. Molecular epidemiological analyses indicate that has been introduced and local transmission has occurred in multiple instances in China. Most isolated from China (98.7%) exhibited resistance to fluconazole, while only a small subset of strains were resistant to amphotericin B (4.2%) and caspofungin (2.2%).